IL27 anticorps
Aperçu rapide pour IL27 anticorps (ABIN1107834)
Antigène
Voir toutes IL27 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- Recognizes both natural and recombinant Human IL-27
-
Réactivité croisée (Details)
- Species reactivity (tested):Human.
-
Purification
- Ion Exchange Chromatography.
-
Stérilité
- 0.22 μm filtered
-
Immunogène
- Recombinant Human IL-27.
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Phosphate-buffered saline without Carrier and preservatives. This prodcut is sterile-filtered through 0.22 μm and treated to remove Endotoxins.
-
Agent conservateur
- Without preservative
-
Stock
- 4 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C.
-
-
- IL27 (Interleukin-27 Subunit alpha (IL27))
-
Autre désignation
- Interleukin-27 / IL27A
-
Sujet
- Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of naive but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-gamma, and T-bet.Synonyms: IL-27 subunit alpha, IL-30, IL27-A, IL30, Interleukin-30, p28
-
ID gène
- 246778
-
NCBI Accession
- NP_663634
-
UniProt
- Q8NEV9
Antigène
-